BioRegenx Revenue

In the year 2025, BioRegenx had annual revenue of $1.85M, down -20.75%. BioRegenx had revenue of $385.64K in the quarter ending December 31, 2025, a decrease of -16.25%.

Revenue

1.85M

Revenue Growth

-20.75%

P/S Ratio

4.70

Revenue / Employee

309.09K

Employees

Market Cap

8.72M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.85M	-485.59K	-20.75%
Dec 31, 2024	2.34M	-1.07M	-31.40%
Dec 31, 2023	3.41M	3.37M	7,991.78%
Dec 31, 2022	42.16K	-3.95M	-98.94%
Dec 31, 2021	3.99M	-3.80M	-48.79%
Dec 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CompuMed	1.69M
DATATRAK International	6.50M
Pharma-Bio Serv	8.82M
Veri Medtech Holdings	11.89M
CareView Communications	9.02M

Revenue Rankings

BioRegenx News

1 year ago - BioRegenx, Inc. Engages Sichenzia Ross Ference Carmel LLP for Legal Representation in Connection with Planned Uplisting to National Stock Exchange - Accesswire

More News